Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Abbreviations
- ARDS:
-
Acute Respiratory Distress Syndrome
- Covid-19:
-
Coronavirus Disease of 2019
- DMV:
-
Double Membraned Vesicles
- ERAD:
-
Endoplasmic Reticulum Associated Protein Degradation
- ER-UPR:
-
Endoplasmic Reticulum Unfolded Protein Response
- Hsp:
-
Heat Shock Protein
- HSF1:
-
Heat Shock Factor 1
- MERS-CoV:
-
Middle East Respiratory Syndrome Coronavirus
- RdRp:
-
RNA-dependent RNA polymerase
- RT-PCR:
-
Reverse Transcription-Polymerase Chain Reaction
- SARS-CoV-2:
-
Severe Acute Respiratory Syndrome Coronavirus 2
- UPS:
-
Ubiquitin Proteasome System
References
Angelini MM, Akhlaghpour M, Neuman BW, Buchmeier MJ (2013) Severe acute respiratory syndrome coronavirus nonstructural proteins 3, 4, and 6 induce double-membrane vesicles. MBio 4
Barretto N, Jukneliene D, Ratia K, Chen Z, Mesecar AD, Baker SC (2005) The papain-like protease of severe acute respiratory syndrome coronavirus has deubiquitinating activity. J Virol 79:15189–15198
Batra J, Tripathi S, Kumar A et al (2016) Human heat shock protein 40 (Hsp40/DnaJB1) promotes influenza a virus replication by assisting nuclear import of viral ribonucleoproteins. Sci Rep 6:19063
Bechill J, Chen Z, Brewer JW, Baker SC (2008) Coronavirus infection modulates the unfolded protein response and mediates sustained translational repression. J Virol 82:4492–4501
Beigel JH, Tomashek KM, Dodd LE et al (2020) Remdesivir for the treatment of Covid-19 - preliminary report. N Engl J Med
Belouzard S, Millet JK, Licitra BN, Whittaker GR (2012) Mechanisms of coronavirus cell entry mediated by the viral spike protein. Viruses 4:1011–1033
Benvenuto D, Angeletti S, Giovanetti M et al (2020) Evolutionary analysis of SARS-CoV-2: how mutation of non-structural protein 6 (NSP6) could affect viral autophagy. J Infect 81:e24–e27
Bonam SR, Muller S, Bayry J, Klionsky DJ (2020) Autophagy as an emerging target for COVID-19: lessons from an old friend, chloroquine. Autophagy
Chan CP, Siu KL, Chin KT, Yuen KY, Zheng B, ** DY (2006) Modulation of the unfolded protein response by the severe acute respiratory syndrome coronavirus spike protein. J Virol 80:9279–9287
Chen PM, Gombart ZJ, Chen JW (2011) Chloroquine treatment of ARPE-19 cells leads to lysosome dilation and intracellular lipid accumulation: possible implications of lysosomal dysfunction in macular degeneration. Cell Biosci 1:10
Cheng Y, Wong R, Soo YO et al (2005) Use of convalescent plasma therapy in SARS patients in Hong Kong. Eur J Clin Microbiol Infect Dis 24:44–46
Chi H, Barry SP, Roth RJ et al (2006) Dynamic regulation of pro- and anti-inflammatory cytokines by MAPK phosphatase 1 (MKP-1) in innate immune responses. Proc Natl Acad Sci U S A 103:2274–2279
Claverie JM (2020) A putative role of de-mono-ADP-Ribosylation of STAT1 by the SARS-CoV-2 Nsp3 protein in the cytokine storm syndrome of COVID-19. Viruses 12
Coronaviridae Study Group of the International Committee on Taxonomy of, V (2020) The species severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5:536–544
Cottam EM, Whelband MC, Wileman T (2014) Coronavirus NSP6 restricts autophagosome expansion. Autophagy 10:1426–1441
de Haan CA, Reggiori F (2008) Are nidoviruses hijacking the autophagy machinery? Autophagy 4:276–279
DeDiego ML, Nieto-Torres JL, Jimenez-Guardeno JM et al (2011) Severe acute respiratory syndrome coronavirus envelope protein regulates cell stress response and apoptosis. PLoS Pathog 7:e1002315
Delmas B, Laude H (1990) Assembly of coronavirus spike protein into trimers and its role in epitope expression. J Virol 64:5367–5375
Deretic V, Saitoh T, Akira S (2013) Autophagy in infection, inflammation and immunity. Nat Rev Immunol 13:722–737
Ding N, Zhao K, Lan Y et al (2017) Induction of atypical autophagy by porcine Hemagglutinating encephalomyelitis virus contributes to viral replication. Front Cell Infect Microbiol 7:56
Donnelly CA, Ghani AC, Leung GM et al (2003) Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 361:1761–1766
Esakandari H, Nabi-Afjadi M, Fakkari-Afjadi J, Farahmandian N, Miresmaeili SM, Bahreini E (2020) A comprehensive review of COVID-19 characteristics. Biol Proced Online 22:19
Fader CM, Colombo MI (2009) Autophagy and multivesicular bodies: two closely related partners. Cell Death Differ 16:70–78
Gao G, Luo H (2006) The ubiquitin-proteasome pathway in viral infections. Can J Physiol Pharmacol 84:5–14
Garcia-Arencibia M, Hochfeld WE, Toh PP, Rubinsztein DC (2010) Autophagy, a guardian against neurodegeneration. Semin Cell Dev Biol 21:691–698
Gassen NC, Niemeyer D, Muth D et al (2019) SKP2 attenuates autophagy through Beclin1-ubiquitination and its inhibition reduces MERS-coronavirus infection. Nat Commun 10:5770
Glickman MH, Ciechanover A (2002) The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev 82:373–428
Gosert R, Kanjanahaluethai A, Egger D, Bienz K, Baker SC (2002) RNA replication of mouse hepatitis virus takes place at double-membrane vesicles. J Virol 76:3697–3708
Guo X, Hu H, Chen F et al (2016) iTRAQ-based comparative proteomic analysis of Vero cells infected with virulent and CV777 vaccine strain-like strains of porcine epidemic diarrhea virus. J Proteomics 130:65–75
Guo X, Zhang M, Zhang X et al (2017) Porcine epidemic diarrhea virus induces autophagy to benefit its replication. Viruses 9
Guo F, Liu X, Cai H, Le W (2018) Autophagy in neurodegenerative diseases: pathogenesis and therapy. Brain Pathol 28:3–13
Hamasaki M, Furuta N, Matsuda A et al (2013) Autophagosomes form at ER-mitochondria contact sites. Nature 495:389–393
Hirayama E, Atagi H, Hiraki A, Kim J (2004) Heat shock protein 70 is related to thermal inhibition of nuclear export of the influenza virus ribonucleoprotein complex. J Virol 78:1263–1270
Hoffmann M, Kleine-Weber H, Schroeder S et al (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181:271–80 e8
Hung IF, Lung KC, Tso EY et al (2020) Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial. Lancet 395:1695–1704
Huotari J, Helenius A (2011) Endosome maturation. EMBO J 30:3481–3500
Hussain S, Pan J, Chen Y et al (2005) Identification of novel subgenomic RNAs and noncanonical transcription initiation signals of severe acute respiratory syndrome coronavirus. J Virol 79:5288–5295
Inoue Y, Tanaka N, Tanaka Y et al (2007) Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. J Virol 81:8722–8729
Isaacson MK, Ploegh HL (2009) Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe 5:559–570
Iwasaki A, Yang Y (2020) The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol 20:339–341
Jiang XS, Tang LY, Dai J et al (2005) Quantitative analysis of severe acute respiratory syndrome (SARS)-associated coronavirus-infected cells using proteomic approaches: implications for cellular responses to virus infection. Mol Cell Proteomics 4:902–913
Kahn JS, McIntosh K (2005) History and recent advances in coronavirus discovery. Pediatr Infect Dis J 24:S223–S227. discussion S26
Kanjanahaluethai A, Chen Z, Jukneliene D, Baker SC (2007) Membrane topology of murine coronavirus replicase nonstructural protein 3. Virology 361:391–401
Killerby ME, Biggs HM, Haynes A et al (2018) Human coronavirus circulation in the United States 2014–2017. J Clin Virol 101:52–56
Kindrachuk J, Ork B, Hart BJ et al (2015) Antiviral potential of ERK/MAPK and PI3K/AKT/mTOR signaling modulation for Middle East respiratory syndrome coronavirus infection as identified by temporal kinome analysis. Antimicrob Agents Chemother 59:1088–1099
Knoops K, Kikkert M, Worm SH et al (2008) SARS-coronavirus replication is supported by a reticulovesicular network of modified endoplasmic reticulum. PLoS Biol 6:e226
Korennykh A, Walter P (2012) Structural basis of the unfolded protein response. Annu Rev Cell Dev Biol 28:251–277
Krahling V, Stein DA, Spiegel M, Weber F, Muhlberger E (2009) Severe acute respiratory syndrome coronavirus triggers apoptosis via protein kinase R but is resistant to its antiviral activity. J Virol 83:2298–2309
Lamb CA, Yoshimori T, Tooze SA (2013) The autophagosome: origins unknown, biogenesis complex. Nat Rev Mol Cell Biol 14:759–774
Lan J, Ge J, Yu J et al (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581:215–220
Law HK, Cheung CY, Ng HY et al (2005) Chemokine up-regulation in SARS-coronavirus-infected, monocyte-derived human dendritic cells. Blood 106:2366–2374
Lee YR, Lei HY, Liu MT et al (2008) Autophagic machinery activated by dengue virus enhances virus replication. Virology 374:240–248
Liao Y, Fung TS, Huang M, Fang SG, Zhong Y, Liu DX (2013) Upregulation of CHOP/GADD153 during coronavirus infectious bronchitis virus infection modulates apoptosis by restricting activation of the extracellular signal-regulated kinase pathway. J Virol 87:8124–8134
Lindner HA, Fotouhi-Ardakani N, Lytvyn V, Lachance P, Sulea T, Menard R (2005) The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J Virol 79:15199–15208
Lindner HA, Lytvyn V, Qi H, Lachance P, Ziomek E, Menard R (2007) Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch Biochem Biophys 466:8–14
Lipsitch M, Cohen T, Murray M, Levin BR (2007) Antiviral resistance and the control of pandemic influenza. PLoS Med 4:e15
Lokugamage KG, Narayanan K, Huang C, Makino S (2012) Severe acute respiratory syndrome coronavirus protein nsp1 is a novel eukaryotic translation inhibitor that represses multiple steps of translation initiation. J Virol 86:13598–13608
Ma XZ, Bartczak A, Zhang J et al (2010) Proteasome inhibition in vivo promotes survival in a lethal murine model of severe acute respiratory syndrome. J Virol 84:12419–12428
Mahase E (2020) Coronavirus covid-19 has killed more people than SARS and MERS combined, despite lower case fatality rate. BMJ 368:m641
Mauthe M, Orhon I, Rocchi C et al (2018) Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy 14:1435–1455
Memish ZA, Al-Tawfiq JA, Assiri A (2013a) Hospital-associated Middle East respiratory syndrome coronavirus infections. N Engl J Med 369:1761–1762
Memish ZA, Zumla AI, Assiri A (2013b) Middle East respiratory syndrome coronavirus infections in health care workers. N Engl J Med 369:884–886
Mizushima N, Levine B (2010) Autophagy in mammalian development and differentiation. Nat Cell Biol 12:823–830
Moutzouris JP, Che W, Ramsay EE et al (2010) Proteasomal inhibition upregulates the endogenous MAPK deactivator MKP-1 in human airway smooth muscle: mechanism of action and effect on cytokine secretion. Biochim Biophys Acta 1803:416–423
Nabar NR, Kehrl JH (2017) The transcription factor EB links cellular stress to the immune response. Yale J Biol Med 90:301–315
Nakagawa K, Lokugamage KG, Makino S (2016) Viral and cellular mRNA translation in coronavirus-infected cells. Adv Virus Res 96:165–192
Nal B, Chan C, Kien F et al (2005) Differential maturation and subcellular localization of severe acute respiratory syndrome coronavirus surface proteins S, M and E. J Gen Virol 86:1423–1434
Oostra M, te Lintelo EG, Deijs M, Verheije MH, Rottier PJ, de Haan CA (2007) Localization and membrane topology of coronavirus nonstructural protein 4: involvement of the early secretory pathway in replication. J Virol 81:12323–12336
Orenstein SJ, Cuervo AM (2010) Chaperone-mediated autophagy: molecular mechanisms and physiological relevance. Semin Cell Dev Biol 21:719–726
Pardo J, Shukla AM, Chamarthi G, Gupte A (2020) The journey of remdesivir: from Ebola to COVID-19. Drugs Context 9
Peng Q, Peng R, Yuan B et al (2020) Structural and biochemical characterization of the nsp12-nsp7-nsp8 Core polymerase complex from SARS-CoV-2. Cell Rep 31:107774
Phillips AM, Gonzalez LO, Nekongo EE et al (2017) Host proteostasis modulates influenza evolution. Elife 6
Phillips AM, Doud MB, Gonzalez LO et al (2018a) Enhanced ER proteostasis and temperature differentially impact the mutational tolerance of influenza hemagglutinin. Elife:7
Phillips AM, Ponomarenko AI, Chen K et al (2018b) Destabilized adaptive influenza variants critical for innate immune system escape are potentiated by host chaperones. PLoS Biol 16:e3000008
Prentice E, Jerome WG, Yoshimori T, Mizushima N, Denison MR (2004) Coronavirus replication complex formation utilizes components of cellular autophagy. J Biol Chem 279:10136–10141
Raaben M, Posthuma CC, Verheije MH et al (2010) The ubiquitin-proteasome system plays an important role during various stages of the coronavirus infection cycle. J Virol 84:7869–7879
Ramadan N, Shaib H (2019) Middle East respiratory syndrome coronavirus (MERS-CoV): a review. Germs 9:35–42
Rappe JCF, de Wilde A, Di H et al (2018) Antiviral activity of K22 against members of the order Nidovirales. Virus Res 246:28–34
Reggiori F, Monastyrska I, Verheije MH et al (2010) Coronaviruses Hijack the LC3-I-positive EDEMosomes, ER-derived vesicles exporting short-lived ERAD regulators, for replication. Cell Host Microbe 7:500–508
Roth-Cross JK, Bender SJ, Weiss SR (2008) Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J Virol 82:9829–9838
Sahu R, Kaushik S, Clement CC et al (2011) Microautophagy of cytosolic proteins by late endosomes. Dev Cell 20:131–139
Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63:1129–1136
Schneider M, Ackermann K, Stuart M et al (2012) Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain. J Virol 86:10112–10122
Settembre C, Di Malta C, Polito VA et al (2011) TFEB links autophagy to lysosomal biogenesis. Science 332:1429–1433
Shi CS, Nabar NR, Huang NN, Kehrl JH (2019) SARS-coronavirus open Reading frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes. Cell Death Dis 5:101
Snijder EJ, van der Meer Y, Zevenhoven-Dobbe J et al (2006) Ultrastructure and origin of membrane vesicles associated with the severe acute respiratory syndrome coronavirus replication complex. J Virol 80:5927–5940
Stertz S, Reichelt M, Spiegel M et al (2007) The intracellular sites of early replication and budding of SARS-coronavirus. Virology 361:304–315
Sun D, Shi H, Guo D et al (2015) Analysis of protein expression changes of the Vero E6 cells infected with classic PEDV strain CV777 by using quantitative proteomic technique. J Virol Methods 218:27–39
Sung SC, Chao CY, Jeng KS, Yang JY, Lai MM (2009) The 8ab protein of SARS-CoV is a luminal ER membrane-associated protein and induces the activation of ATF6. Virology 387:402–413
Tan YJ, Lim SG, Hong W (2006) Understanding the accessory viral proteins unique to the severe acute respiratory syndrome (SARS) coronavirus. Antiviral Res 72:78–88
Versteeg GA, van de Nes PS, Bredenbeek PJ, Spaan WJ (2007) The coronavirus spike protein induces endoplasmic reticulum stress and upregulation of intracellular chemokine mRNA concentrations. J Virol 81:10981–10990
Wang J (2020) Fast identification of possible drug treatment of coronavirus Disease-19 (COVID-19) through computational drug repurposing study. J Chem Inf Model
Wang X, Liao Y, Yap PL, Png KJ, Tam JP, Liu DX (2009) Inhibition of protein kinase R activation and upregulation of GADD34 expression play a synergistic role in facilitating coronavirus replication by maintaining de novo protein synthesis in virus-infected cells. J Virol 83:12462–12472
Wang X, Cao R, Zhang H et al (2020a) The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro. Cell Discov 6:28
Wang Y, Zhang D, Du G et al (2020b) Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet 395:1569–1578
Weissman AM (2001) Themes and variations on ubiquitylation. Nat Rev Mol Cell Biol 2:169–178
**a X, Li K, Wu L et al (2020) Improved clinical symptoms and mortality on severe/critical COVID-19 patients utilizing convalescent plasma transfusion. Blood
Xu X, Han M, Li T et al (2020) Effective treatment of severe COVID-19 patients with tocilizumab. Proc Natl Acad Sci U S A 117:10970–10975
Yang ZY, Huang Y, Ganesh L et al (2004) pH-dependent entry of severe acute respiratory syndrome coronavirus is mediated by the spike glycoprotein and enhanced by dendritic cell transfer through DC-SIGN. J Virol 78:5642–5650
Yang J, Zheng Y, Gou X et al (2020) Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis 94:91–95
Ye Y, Hauns K, Langland JO, Jacobs BL, Hogue BG (2007) Mouse hepatitis coronavirus A59 nucleocapsid protein is a type I interferon antagonist. J Virol 81:2554–2563
Yeung YS, Yip CW, Hon CC et al (2008) Transcriptional profiling of Vero E6 cells over-expressing SARS-CoV S2 subunit: insights on viral regulation of apoptosis and proliferation. Virology 371:32–43
Yu GY, Lai MM (2005) The ubiquitin-proteasome system facilitates the transfer of murine coronavirus from endosome to cytoplasm during virus entry. J Virol 79:644–648
Yuan W, Liu S, Lu L, Feng J, He X (2020) Clinical interventions for severe and critical COVID-19: what are the options. Am J Transl Res 12:2110–2117
Zhao Z, Thackray LB, Miller BC et al (2007) Coronavirus replication does not require the autophagy gene ATG5. Autophagy 3:581–585
Zhao L, Rose KM, Elliott R, Van Rooijen N, Weiss SR (2011) Cell-type-specific type I interferon antagonism influences organ tropism of murine coronavirus. J Virol 85:10058–10068
Zhao L, Jha BK, Wu A et al (2012) Antagonism of the interferon-induced OAS-RNase L pathway by murine coronavirus ns2 protein is required for virus replication and liver pathology. Cell Host Microbe 11:607–616
Zhao X, Guo F, Comunale MA et al (2015) Inhibition of endoplasmic reticulum-resident glucosidases impairs severe acute respiratory syndrome coronavirus and human coronavirus NL63 spike protein-mediated entry by altering the glycan processing of angiotensin I-converting enzyme 2. Antimicrob Agents Chemother 59:206–216
Zhou P, Yang XL, Wang XG et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579:270–273
Zust R, Cervantes-Barragan L, Habjan M et al (2011) Ribose 2'-O-methylation provides a molecular signature for the distinction of self and non-self mRNA dependent on the RNA sensor Mda5. Nat Immunol 12:137–143
Acknowledgments
KM acknowledges the funding from Department of Biotechnology (DBT), Government of India, grant number (BT/PR28386/BRB/10/1671/2018) and Science and Engineering Research Board (SERB), Government of India, for Core Research Grant (SERB/CRG/2019/006281) and SNU core funding. PM acknowledges SERB NPDF grant (SERB/F/4161/2018-2019). RS acknowledges ICMR SRF grant (2019-6710/CMB/BMS) and SNU PhD fellowship. MA and MPJ acknowledge SNU PhD fellowship.
Conflict of Interest
There is no conflict of interest with the contents of the book chapter.
Ethical Approval for Studies Involving Humans
This chapter does not contain any studies with human participants performed by any of the authors.
Ethical Approval for Studies Involving Animals
This chapter does not contain any studies with animals performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ali, M., Rajurkar, J., Majumder, P., Jha, M.P., Sarkar, R., Mapa, K. (2021). Possible Therapeutic Intervention Strategies for COVID-19 by Manipulating the Cellular Proteostasis Network. In: Asea, A.A.A., Kaur, P. (eds) Coronavirus Therapeutics – Volume I. Advances in Experimental Medicine and Biology, vol 1352. Springer, Cham. https://doi.org/10.1007/978-3-030-85109-5_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-85109-5_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-85108-8
Online ISBN: 978-3-030-85109-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)